Origin of developmental precursors dictates the pathophysiologic role of cardiac fibroblasts

Journal of Cardiovascular Translational Research

Volumn 5, Issue 6, 2012, Pages 749-759

  Crawford, Jeffrey R ^a   Haudek, Sandra B ^a   Cieslik, Katarzyna A ^a   Trial, Joann ^a   Entman, Mark L ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cardiac scar formation; Fibroblasts in the aging heart; Immunoinflammatory dysregulation; Mesenchymal stem cells; Myeloid fibroblasts

Indexed keywords

ADENYLATE KINASE; AUTACOID; CD45 ANTIGEN; INTERLEUKIN 12; INTERLEUKIN 13; INTERLEUKIN 4; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SERUM AMYLOID P; TRANSCRIPTION FACTOR NANOG; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1;

AGING; ARTICLE; CARDIAC FIBROBLAST; CELL DIFFERENTIATION; EPITHELIAL MESENCHYMAL TRANSITION; FIBROBLAST; HEART INFARCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; HUMAN; INFLAMMATION; MESENCHYMAL STEM CELL; MONOCYTE; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; SCAR FORMATION; SIGNAL TRANSDUCTION; ANIMAL; CELL LINEAGE; EXTRACELLULAR MATRIX; FIBROSIS; HEART FAILURE; HEART MUSCLE; MESENCHYMAL STROMA CELL; METABOLISM; MYELOID PROGENITOR CELL; MYOFIBROBLAST; PATHOLOGY; REVIEW; SCAR;

ANIMALS; CELL DIFFERENTIATION; CELL LINEAGE; CICATRIX; EXTRACELLULAR MATRIX; FIBROBLASTS; FIBROSIS; HEART FAILURE; HUMANS; MESENCHYMAL STROMAL CELLS; MYELOID PROGENITOR CELLS; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOFIBROBLASTS;

EID: 84878201717     PISSN: 19375387     EISSN: 19375395     Source Type: Journal    
DOI: 10.1007/s12265-012-9402-7     Document Type: Article

References (51)

1. Sun, Y.; Kiani, M. F.; Postlethwaite, A. E.; & Weber, K. T. (2002). Infarct scar as living tissue. Basic Research in Cardiology, 97, 343-347.
2. Weber, K. T. (1989). Cardiac interstitium in health and disease: the fibrillar collagen network. Journal of the American College of Cardiology, 13, 1637-1652.
3. Bing, O. H.; Matsushita, S.; Fanburg, B. L.; & Levine, H. J. (1971). Mechanical properties of rat cardiac muscle during experimental hypertrophy. Circulation Research, 28, 234-245.
4. Jalil, J. E.; Janicki, J. S.; Pick, R.; Abrahams, C.; & Weber, K. T. (1989). Fibrosis-induced reduction of endomyocardium in the rat after isoproterenol treatment. Circulation Research, 65, 258-264.
5. Thiedemann, K. U.; Holubarsch, C.; Medugorac, I.; & Jacob, R. (1983). Connective tissue content and myocardial stiffness in pressure overload hypertrophy. A combined study of morphologic, morphometric, biochemical, and mechanical parameters. Basic Research in Cardiology, 78, 140-155.
6. Weber, K. T.; Brilla, C. G.; & Janicki, J. S. (1993). Myocardial fibrosis: functional significance and regulatory factors. Cardiovascular Research, 27, 341-348.
7. Weber, K. T.; Pick, R.; Jalil, J. E.; Janicki, J. S.; & Carroll, E. P. (1989). Patterns of myocardial fibrosis. Journal of Molecular and Cellular Cardiology, 21(Suppl 5), 121-131.
8. Carlson, S.; Trial, J.; Soeller, C.; & Entman, M. L. (2011). Cardiac mesenchymal stem cells contribute to scar formation after myocardial infarction. Cardiovascular Research, 91, 99-107.
9. Kalluri, R.; & Neilson, E. G. (2003). Epithelial-mesenchymal transition and its implications for fibrosis. The Journal of Clinical Investigation, 112, 1776-1784.
10. Zeisberg, E. M.; Tarnavski, O.; Zeisberg, M.; Dorfman, A. L.; McMullen, J. R.; Gustafsson, E.; et al. (2007). Endothelial-to-mesenchymal transition contributes to cardiac fibrosis. Nature Medicine, 13, 952-961.
11. Esposito, M. T.; Di Noto, R.; Mirabelli, P.; Gorrese, M.; Parisi, S.; Montanaro, D.; et al. (2009). Culture conditions allow selection of different mesenchymal progenitors from adult mouse bone marrow. Tissue Engineering. Part A, 15, 2525-2536.
12. Sarugaser, R.; Hanoun, L.; Keating, A.; Stanford, W. L.; & Davies, J. E. (2009). Human mesenchymal stem cells self-renew and differentiate according to a deterministic hierarchy. PLoS One, 4, e6498.
13. Bucala, R.; Spiegel, L. A.; Chesney, J.; Hogan, M.; & Cerami, A. (1994). Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Molecular Medicine, 1, 71-81.
14. Pilling, D.; Fan, T.; Huang, D.; Kaul, B.; & Gomer, R. H. (2009). Identification of markers that distinguish monocyte-derived fibrocytes from monocytes, macrophages, and fibroblasts. PLoS One, 4, e7475.
15. Abe, R.; Donnelly, S. C.; Peng, T.; Bucala, R.; & Metz, C. N. (2001). Peripheral blood fibrocytes: differentiation pathway and migration to wound sites. Journal of Immunology, 166, 7556-7562.
16. Yang, L.; Scott, P. G.; Giuffre, J.; Shankowsky, H. A.; Ghahary, A.; & Tredget, E. E. (2002). Peripheral blood fibrocytes from burn patients: identification and quantification of fibrocytes in adherent cells cultured from peripheral blood mononuclear cells. Laboratory Investigation, 82, 1183-1192.
17. Hashimoto, N.; Jin, H.; Liu, T.; Chensue, S. W.; & Phan, S. H. (2004). Bone marrow-derived progenitor cells in pulmonary fibrosis. The Journal of Clinical Investigation, 113, 243-252.
18. Phillips, R. J.; Burdick, M. D.; Hong, K.; Lutz, M. A.; Murray, L. A.; Xue, Y. Y.; et al. (2004). Circulating fibrocytes traffic to the lungs in response to CXCL12 and mediate fibrosis. The Journal of Clinical Investigation, 114, 438-446.
19. Schmidt, M.; Sun, G.; Stacey, M. A.; Mori, L.; & Mattoli, S. (2003). Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. Journal of Immunology, 171, 380-389.
20. Moore, B. B.; Kolodsick, J. E.; Thannickal, V. J.; Cooke, K.; Moore, T. A.; Hogaboam, C.; et al. (2005). CCR2-mediated recruitment of fibrocytes to the alveolar space after fibrotic injury. American Journal of Pathology, 166, 675-684.
21. Pilling, D.; Buckley, C. D.; Salmon, M.; & Gomer, R. H. (2003). Inhibition of fibrocyte differentiation by serum amyloid P. Journal of Immunology, 171, 5537-5546.
22. Pilling, D.; Tucker, N. M.; & Gomer, R. H. (2006). Aggregated IgG inhibits the differentiation of human fibrocytes. Journal of Leukocyte Biology, 79, 1242-1251.
23. Shao, D. D.; Suresh, R.; Vakil, V.; Gomer, R. H.; & Pilling, D. (2008). Pivotal advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. Journal of Leukocyte Biology, 83, 1323-1333.
24. Wynn, T. A. (2008). Cellular and molecular mechanisms of fibrosis. The Journal of Pathology, 214, 199-210.
25. Dewald, O.; Frangogiannis, N. G.; Zoerlein, M.; Duerr, G. D.; Klemm, C.; Knuefermann, P.; et al. (2003). Development of murine ischemic cardiomyopathy is associated with a transient inflammatory reaction and depends on reactive oxygen species. Proceedings of the National Academy of Sciences, USA, 100, 2700-2705.
26. Haudek, S. B.; Xia, Y.; Huebener, P.; Lee, J. M.; Carlson, S.; Crawford, J. R.; et al. (2006). Bone marrow-derived fibroblast precursors mediate ischemic cardiomyopathy in mice. Proceedings of the National Academy of Sciences of the United States of America, 103, 18284-18289.
27. Dewald, O.; Ren, G.; Duerr, G. D.; Zoerlein, M.; Klemm, C.; Gersch, C.; et al. (2004). Of mice and dogs: species-specific differences in the inflammatory response following myocardial infarction. American Journal of Pathology, 164, 665-677.
28. Frangogiannis, N. G.; Mendoza, L. H.; Lewallen, M.; Michael, L. H.; Smith, C. W.; & Entman, M. L. (2001). Induction and suppression of interferon-inducible protein (IP)-10 in reperfused myocardial infarcts may regulate angiogenesis. The FASEB Journal, 15, 1428-1430.
29. Kukielka, G. L.; Smith, C. W.; LaRosa, G. J.; Manning, A. M.; Mendoza, L. H.; Hughes, B. J.; et al. (1995). Interleukin-8 gene induction in the myocardium after ischemia and reperfusion in vivo. The Journal of Clinical Investigation, 95, 89-103.
30. Kumar, A. G.; Ballantyne, C. M.; Michael, L. H.; Kukielka, G. L.; Youker, K. A.; Lindsey, M. L.; et al. (1997). Induction of monocyte chemoattractant protein-1 in the small veins of the ischemic and reperfused canine myocardium. Circulation, 95, 693-700.
31. Lakshminarayanan, V.; Lewallen, M.; Frangogiannis, N. G.; Evans, A. J.; Wedin, K. E.; Michael, L. H.; et al. (2001). Reactive oxygen intermediates induce monocyte chemotactic protein-1 in vascular endothelium after brief ischemia. American Journal of Pathology, 159, 1301-1311.
32. Frangogiannis, N. G.; Dewald, O.; Xia, Y.; Ren, G.; Haudek, S.; Leucker, T.; et al. (2007). Critical role of monocyte chemoattractant protein-1/CC chemokine ligand 2 in the pathogenesis of ischemic cardiomyopathy. Circulation, 115, 584-592.
33. Frangogiannis, N. G.; Ren, G.; Dewald, O.; Zymek, P.; Koerting, A.; Winkelmann, K.; et al. (2005). Critical role of endogenous thrombospondin (TSP)-1 in preventing expansion of healing myocardial infarcts. Circulation, 111, 2935-2942.
34. Haudek, S. B.; Trial, J.; Xia, Y.; Gupta, D.; Pilling, D.; & Entman, M. L. (2008). Fc receptor engagement mediates differentiation of cardiac fibroblast precursor cells. Proceedings of the National Academy of Sciences of the United States of America, 105, 10179-10184.
35. Moreira, A. P.; Cavassani, K. A.; Hullinger, R.; Rosada, R. S.; Fong, D. J.; Murray, L.; et al. (2010). Serum amyloid P attenuates M2 macrophage activation and protects against fungal spore-induced allergic airway disease. The Journal of Allergy and Clinical Immunology, 126, 712-721.
36. Murray, L. A.; Chen, Q.; Kramer, M. S.; Hesson, D. P.; Argentieri, R. L.; Peng, X.; et al. (2011). TGF-beta driven lung fibrosis is macrophage dependent and blocked by serum amyloid P. The International Journal of Biochemistry & Cell Biology, 43, 154-162.
37. Cieslik, K. A.; Taffet, G. E.; Carlson, S.; Hermosillo, J.; Trial, J.; & Entman, M. L. (2011). Immune-inflammatory dysregulation modulates the incidence of progressive fibrosis and diastolic stiffness in the aging heart. Journal of Molecular and Cellular Cardiology, 50, 248-256.
38. Friedrich, K.; Brändlein, S.; Ehrhardt, I.; & Krause, S. (2003). Interleukin-4- and interleukin-13 receptors trigger distinct JAK/STAT activation patterns inmouse lymphocytes. Signal Transduction, 1-2, 26-32.
39. Ingram, J. L.; Rice, A. B.; Geisenhoffer, K.; Madtes, D. K.; & Bonner, J. C. (2004). IL-13 and IL-1beta promote lung fibroblast growth through coordinated up-regulation of PDGF-AA and PDGF-Ralpha. The FASEB Journal, 18, 1132-1134.
40. Haudek, S. B.; Gupta, D.; Dewald, O.; Schwartz, R. J.; Wei, L.; Trial, J.; et al. (2009). Rho kinase-1 mediates cardiac fibrosis by regulating fibroblast precursor cell differentiation. Cardiovascular Research, 83, 511-518.
41. Medina, A.; & Ghahary, A. (2010). Fibrocytes can be reprogrammed to promote tissue remodeling capacity of dermal fibroblasts. Molecular Cell Biochem, 344(1-2), 11-21.
42. Wang, J. F.; Jiao, H.; Stewart, T. L.; Shankowsky, H. A.; Scott, P. G.; & Tredget, E. E. (2007). Fibrocytes from burn patients regulate the activities of fibroblasts. Wound Repair and Regeneration, 15, 113-121.
43. Liao, W. T.; Yu, H. S.; Arbiser, J. L.; Hong, C. H.; Govindarajan, B.; Chai, C. Y.; et al. (2010). Enhanced MCP-1 release by keloid CD14+ cells augments fibroblast proliferation: role of MCP-1 and Akt pathway in keloids. Experimental Dermatology, 19, e142-e150.
44. Haudek, S. B.; Cheng, J.; Du, J.; Wang, Y.; Hermosillo-Rodriguez, J.; Trial, J.; et al. (2010). Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy. Journal of Molecular and Cellular Cardiology, 49, 499-507.
45. Chen, G.; Lin, S. C.; Chen, J.; He, L.; Dong, F.; Xu, J.; et al. (2011). CXCL16 recruits bone marrow-derived fibroblast precursors in renal fibrosis. Journal of the American Society of Nephrology, 22, 1876-1886.
46. Dewald, O.; Zymek, P.; Winkelmann, K.; Koerting, A.; Ren, G.; Michael, L. H.; et al. (2005). CCL2/monocyte chemoattractant protein (MCP)-1 regulates inflammatory responses critical to healing myocardial infarcts. Circulation Research, 96, 881-889.
47. Bujak, M.; Kweon, H. J.; Chatila, K.; Li, N.; Taffet, G.; & Frangogiannis, N. G. (2008). Aging-related defects are associated with adverse cardiac remodeling in a mouse model of reperfused myocardial infarction. Journal of the American College of Cardiology, 51, 1384-1392.
48. Gould, K. E.; Taffet, G. E.; Michael, L. H.; Christie, R. M.; Konkol, D. L.; Pocius, J. S.; et al. (2002). Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. American Journal of Physiology - Heart and Circulatory Physiology, 282, H615-H621.
49. Thakker, G. D.; Frangogiannis, N. G.; Bujak, M.; Zymek, P.; Gaubatz, J. W.; Reddy, A. K.; et al. (2006). Effects of diet-induced obesity on inflammation and remodeling after myocardial infarction. American Journal of Physiology - Heart and Circulatory Physiology, 291, H2504-H2514.
50. Goldsmith, E. C.; Hoffman, A.; Morales, M. O.; Potts, J. D.; Price, R. L.; McFadden, A.; et al. (2004). Organization of fibroblasts in the heart. Developmental Dynamics, 230, 787-794.
51. Cieslik, K. A.; Trial, J.; & Entman, M. L. (2011). Defective mesenchymal stem cell differentiation in aging murine heart: rescue by Tak1/AMPK/p38 MAPK pathway. American Journal of Pathology, 179, 1792-1806.